Business Wire

OR-LATTICE-SEMICONDUCTOR

12.8.2020 22:02:08 CEST | Business Wire | Press release

Share
Lattice Sentry Solutions Stack and SupplyGuard Service Deliver End-to-End Supply Chain Protection with Dynamic Trust

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today launched the Lattice Sentry™ solutions stack and the Lattice SupplyGuard™ supply chain protection service. The Sentry stack is a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193). The Lattice SupplyGuard service extends the system protection provided by the Sentry stack throughout today’s challenging and rapidly changing supply chain by delivering factory-locked devices to protect them from attacks like cloning and malware insertion, and enables secure device ownership transfer. These hardware security solutions are increasingly important to a range of applications, including communications, datacenter, industrial, automotive, aerospace, and client computing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005214/en/

According to Patrick Moorhead, president and founder of Moor Insights & Strategy, “5G, Edge computing, and IoT are accelerating the pace at which devices are becoming connected, and security concerns are on the rise among high-tech OEMs serving every market. Developers need to know their hardware platforms are secured against cyberattack and IP theft. They need security solutions that support comprehensive protection throughout a product’s entire operating life in the field, which means the solution must be able to dynamically adapt to an evolving threat landscape.”

“Lattice continues to execute to our solutions stack roadmap and strategy to provide our customers with easy to use, system-level solutions for key focus applications. The Lattice Sentry solutions stack makes it easy for customers to implement a hardware Root-of-Trust (RoT)-based PFR solution compliant with the NIST SP-800-193 guidelines,” said Deepak Boppana, Sr. Director, Segments and Solutions Marketing, Lattice. “With Sentry’s validated IPs, pre-verified reference designs, and hardware demos, developers can quickly customize the PFR solution by modifying the C code provided with the RISC-V and Propel design environment to cut time-to-market from ten months to just six weeks.”

The security paradigm is changing, and firmware is an increasingly popular attack vector. The National Vulnerability Database reported that between 2016 and 2019 the number of firmware vulnerabilities grew over 700 percent1 . Protecting systems against unauthorized firmware access requires dynamic, persistent, real-time hardware platform security for all connected devices. This includes securing component firmware from unauthorized access and enabling the system to automatically protect, detect, and recover from an attack in an instant. TPM and MCU-based hardware security solutions use serial processing and cannot deliver the real-time performance that parallel processing solutions like Lattice FPGAs can.

“To provide them with peace of mind in a constantly changing and increasingly risky supply chain environment, Lattice developed our SupplyGuard service to help our customers securely provision their devices while lowering their overall costs,” said Eric Sivertson, Vice President of Security Business, Lattice. “With Sentry and SupplyGuard, Lattice delivers comprehensive, truly parallel, nanosecond reactive, next-generation security to enable dynamic trust for our customers and the users of their products.”

Key features of the Lattice Sentry solutions stack include:

  • Hardware security capabilities – the Sentry solutions stack provides a pre-verified, NIST-compliant PFR implementation that enforces strict, real-time access controls to all system firmware during and after system boot. If corrupt firmware is detected, Sentry can automatically rollback to a previously known good state version of the firmware so secure system operation continues without interruption.
  • Compliance with latest NIST SP-800-193 standard and CAVP certifications – the stack enables implementation of a hardware RoT through its support for the cryptographically-sound Lattice MachXO3D™ family of FPGAs.
  • Ease of use – developers can drag-and-drop Sentry’s validated IPs and modify the included RISC-V C reference code in the Lattice Propel design environment without any prior FPGA experience.
  • Rapid time-to-market – the Sentry stack provides pre-verified and tested application demos, reference designs, and development boards that can slash development times for PFR applications from ten months to just six weeks.
  • Flexible, platform-agnostic security solution – Sentry offers comprehensive, real-time PFR support for firmware and programmable peripherals. It can act as a RoT in a system and/or complement any existing BMC/MCU/TPM-based architecture for full NIST SP-800-193 compliance.

Key features of the Lattice SupplyGuard supply chain protection service include:

  • Robust security throughout device lifecycle – SupplyGuard is a subscribed service that offers OEMs and ODMs peace of mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport through the global supply chain, system integration and assembly, initial configuration, and deployment. SupplyGuard helps protect OEMs by:
    • Ensuring only authorized manufacturers can build an OEM’s design, regardless of their location.
    • Providing OEMs with a secure key infrastructure to prevent the activation of their IP on unauthorized components to stop product cloning and overbuilding.
    • Securing devices against the download and installation of Trojans, malware, or other unauthorized software to protect platforms and systems against equipment hijacking or other cyberattacks.
  • Flexible, low-cost implementation – SupplyGuard is highly customizable to meet the specific security and supply chain needs of OEMs in every industry Lattice serves. The service lowers the operating costs associated with implementing a secure manufacturing ecosystem.

For more information, please visit www.latticesemi.com/LatticeSentry and www.latticesemi.com/LatticeSupplyGuard

About Lattice Semiconductor

Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.

For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .

Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.

GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.

1 Source: National Vulnerability Database (2016 and 2019 )

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye